Filter
2418
Filtered Results: 2418
Text search:
World
Health
Organization
(South-East-Asia)
Featured
Recommendations
200
New Publications
601
Language
Document type
No document type
1261
Studies & Reports
607
Guidelines
240
Manuals
114
Strategic & Response Plan
79
Fact sheets
34
Training Material
29
Situation Updates
23
Resource Platforms
16
Infographics
9
Brochures
3
Online Courses
3
Countries / Regions
Global
172
India
99
Myanmar / Burma
90
South–East Asia Region
89
Nepal
64
Bangladesh
51
Asia
51
Philippines
39
Indonesia
39
Africa
36
Western and Central Europe
31
Cambodia
29
South Africa
24
Ethiopia
23
Uganda
22
Kenya
22
Nigeria
19
Syria
19
Middle East and North Africa
18
Tanzania
16
Thailand
16
Western Pacific Region
16
Pakistan
14
Latin America and the Carribbean
14
Liberia
13
Congo, Democratic Republic of
13
Zambia
13
West and Central Africa
13
Afghanistan
12
East and Southern Africa
12
Ghana
11
Malawi
11
Mozambique
11
Ukraine
11
Eastern Europe
11
Haiti
10
China
10
Rwanda
10
Yemen
10
Russia
9
Vietnam
9
Zimbabwe
8
South Sudan
8
Brazil
8
Sierra Leone
7
Laos
7
Senegal
6
Somalia
6
Sri Lanka
6
Eastern Europe and Central Asia
6
Cameroon
5
Sudan
5
Burkina Faso
4
Jordan
4
Malaysia
4
Central African Republic
4
Madagascar
4
Venezuela
4
Timor Leste/ East Timor
4
Moldova
4
Iran
4
Georgia
4
Japan
4
Guinea
3
USA
3
Turkey
3
Egypt
3
Papua New Guinea
3
Namibia
3
North Macedonia
3
Botswana
3
Albania
3
Bosnia and Herzegovina
3
Mali
2
Iraq
2
Lebanon
2
Eswatini/ Swaziland
2
Serbia
2
Croatia
2
Colombia
2
Mexico
2
North Korea
2
Italy
2
Tajikistan
2
Kyrgyzstan
2
Kazakhstan
2
Turkmenistan
2
Belarus
2
Morocco
1
Saudi Arabia
1
Niger
1
Singapore
1
Benin
1
Vanuatu
1
Argentina
1
Peru
1
Hungary
1
Honduras
1
Ecuador
1
Bolivia
1
Greece
1
Libya
1
Angola
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Romania
1
Gabon
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
599
Clinical Guidelines
262
Public Health
178
Women & Child Health
164
Key Resources
123
Capacity Building
51
Pharmacy & Technologies
31
Toolboxes
HIV
238
Mental Health
213
Planetary Health
171
COVID-19
154
TB
117
NTDs
104
AMR
96
Rapid Response
85
Disability
84
Global Health Education
76
NCDs
59
Refugee
54
Caregiver
53
Natural Hazards
42
Conflict
40
Health Financing Toolbox
39
Pharmacy
34
Zika
28
Ebola
21
Polio
16
Cholera
14
Specific Hazards
9
Typhoon
3
Social Ethics
2
Health Financing
1
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the ... of users as well as to others and society at large. It provides WHO recommendations for the most effective prevention measures in Viet Nam and will also help answer questions that policy makers may have on how to develop effective policies for prevention and control of alcohol related harms.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sust...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicabl...
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing) and eye-seeking flies (particularly Musca sorbens)...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health ... (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting was attended by representatives from the health ministries of Albania, Georgia, Greece, Iran (Islamic Republic of), Iraq, Jordan, Lebanon, Morocco, Pakistan, Saudi Arabia, Sudan, Syrian Arab Republic and Tunisia. Representatives from Afghanistan, Algeria and Libya were unable to attend. The Secretariat comprised staff from WHO headquarters, WHO regional offices in the Eastern Mediterranean, Africa and Europe, WHO country offices in Iraq, Pakistan, Syrian Arab Republic and Yemen, and WHO temporary advisors from Spain and Tunisia.
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
En la actualidad, los daños que sufren los pacientes a causa de una atención poco segura constituyen un desafío
importante y creciente para la salud pública mundial y son una de las principales causas de muerte y discapacidad
en todo el mundo. La mayor parte de estos daños son evitables. Ahor...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
La filariose lymphatique (FL) est une maladie évitable, incapacitante et défigurante, due à une infestation par des filaires parasites des espèces Wuchereria bancrofti, Brugia malayi et B. timori. On estime que 51,4 millions de personnes sont infectées dans le monde. Le lymphœdème et l’hydr...
This volume contains monographs prepared at the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met virtually online from 1 to 12 February 2021.
The detailed monographs in this volume summarize data on specific contaminants in food. Individual monographs ...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
